These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis.
    Author: Rozwarski DA, Grant GA, Barton DH, Jacobs WR, Sacchettini JC.
    Journal: Science; 1998 Jan 02; 279(5347):98-102. PubMed ID: 9417034.
    Abstract:
    The preferred antitubercular drug isoniazid specifically targets a long-chain enoyl-acyl carrier protein reductase (InhA), an enzyme essential for mycolic acid biosynthesis in Mycobacterium tuberculosis. Despite the widespread use of this drug for more than 40 years, its precise mode of action has remained obscure. Data from x-ray crystallography and mass spectrometry reveal that the mechanism of isoniazid action against InhA is covalent attachment of the activated form of the drug to the nicotinamide ring of nicotinamide adenine dinucleotide bound within the active site of InhA.
    [Abstract] [Full Text] [Related] [New Search]